That’s why, as a 2016 Vox investigation found, there are many reports of vitamins and supplements containing ingredients that ...

Bloomberg / Contributor / Getty Images Shares of Hims & Hers Health (HIMS) plunged in late trading Monday after the company reported falling margins as costs rose, overshadowing better-than ...

Hims & Hers Health said fourth-quarter revenue surged as demand for its weight-loss treatments took off throughout the year amid a competitor supply shortage. The telehealth-consultation platform ...

Hims & Hers Health reported fourth-quarter results on Monday that beat analysts' expectations, but the stock sank in extended trading. Revenue increased 95% from a year earlier to $481 million ...

Direct-to-consumer telehealth company Hims & Hers is forging ahead in the aftermath of the semaglutide shortage ending last week. Hims & Hers faces new headwinds in its weight management segment ...

Online health and wellness company Hims & Hers reported fourth-quarter earnings that beat Wall Street analysts' expectations and gave upbeat guidance for 2025. But shares of the company dropped 19 ...

Shares of Hims & Hers Health (HIMS) sank in after-hours trading after the healthcare company reported earnings for its fourth quarter of Fiscal Year 2024 that were accompanied by a solid outlook.

Feb 24 (Reuters) - Hims & Hers (HIMS.N), opens new tab said on Monday that it may no longer be able to sell compounded versions of the weight-loss drug made by Novo Nordisk (NOVOb.CO), opens new ...

Hims & Hers Health stock opened at $49.10 on Friday. The business’s 50-day simple moving average is $35.05 and its two-hundred day simple moving average is $25.70. The company has a market cap ...

Hims & Hers has shown exceptional growth, with a 1,000% appreciation since our first bullish rating, driven by strong growth, margins, and strategic expansions. Despite the impressive ...